155 related articles for article (PubMed ID: 10665924)
1. Nodular glomerulosclerosis secondary to mu heavy chain deposits.
Liapis H; Papadakis I; Nakopoulou L
Hum Pathol; 2000 Jan; 31(1):122-5. PubMed ID: 10665924
[TBL] [Abstract][Full Text] [Related]
2. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis.
Yasuda T; Fujita K; Imai H; Morita K; Nakamoto Y; Miura AB
Clin Nephrol; 1995 Dec; 44(6):394-9. PubMed ID: 8719552
[TBL] [Abstract][Full Text] [Related]
3. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.
Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW
Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927
[TBL] [Abstract][Full Text] [Related]
4. Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1.
Moulin B; Deret S; Mariette X; Kourilsky O; Imai H; Dupouet L; Marcellin L; Kolb I; Aucouturier P; Brouet JC; Ronco PM; Mougenot B
J Am Soc Nephrol; 1999 Mar; 10(3):519-28. PubMed ID: 10073602
[TBL] [Abstract][Full Text] [Related]
5. Nodular glomerulosclerosis associated with multiple myeloma. Role of light chain isoelectric point.
Palant CE; Bonitati J; Bartholomew WR; Brentjens JR; Walshe JJ; Bentzel CJ
Am J Med; 1986 Jan; 80(1):98-102. PubMed ID: 3079952
[TBL] [Abstract][Full Text] [Related]
6. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
7. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease.
Tubbs RR; Berkley V; Valenzuela R; McMahon JT; Gephardt GN; Fishleder AJ; Nally JV; Pohl MA; Bukowski RM; Lichtin AE
Mod Pathol; 1992 Mar; 5(2):185-90. PubMed ID: 1574496
[TBL] [Abstract][Full Text] [Related]
8. Cast nephropathy in mu heavy chain disease.
Preud'homme JL; Bauwens M; Dumont G; Goujon JM; Dreyfus B; Touchard G
Clin Nephrol; 1997 Aug; 48(2):118-21. PubMed ID: 9285150
[TBL] [Abstract][Full Text] [Related]
9. [A case report of light and heavy chain deposition disease (IgG2 lambda)].
Akashi Y; Yoshizawa N; Oshima S; Takeuchi A; Kubota T; Kondo S; Oshikawa Y; Oda T; Suzuki Y; Shimizu J
Nihon Jinzo Gakkai Shi; 1994 Sep; 36(9):1057-66. PubMed ID: 7967178
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case.
Herzenberg AM; Lien J; Magil AB
Am J Kidney Dis; 1996 Jul; 28(1):128-31. PubMed ID: 8712207
[TBL] [Abstract][Full Text] [Related]
11. A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy.
Nakatsuka A; Maeshima Y; Sarai A; Yanai H; Sugiyama H; Yamasaki Y; Makino H
Clin Nephrol; 2005 Sep; 64(3):221-7. PubMed ID: 16175947
[TBL] [Abstract][Full Text] [Related]
12. Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow.
Kaneko K; Seta K; Soma J; Kuwahara T; Koizumi M; Kikuchi Y; Sugawara A; Yahata K
CEN Case Rep; 2014 May; 3(1):44-48. PubMed ID: 28509245
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
[TBL] [Abstract][Full Text] [Related]
14. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
[TBL] [Abstract][Full Text] [Related]
15. Mu-heavy chain disease associated with systemic amyloidosis.
Kinoshita K; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M; Kanamaru A
Hematology; 2004 Apr; 9(2):135-7. PubMed ID: 15203869
[TBL] [Abstract][Full Text] [Related]
16. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
[TBL] [Abstract][Full Text] [Related]
17. Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenström's macroglobulinemia: case report and review of the literature.
Yahata M; Nakaya I; Takahashi S; Sakuma T; Sato H; Soma J
Clin Nephrol; 2012 Mar; 77(3):254-60. PubMed ID: 22377259
[TBL] [Abstract][Full Text] [Related]
18. Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysis and evidence for morphologic transitions.
Hirszel P; Yamase HT; Carney WR; Galen MA; Graeber CW; Johnson KJ; Kennedy TL; Lapkin RA; McLean RH; Rosenworcel E
Nephron; 1984; 38(2):100-8. PubMed ID: 6382035
[TBL] [Abstract][Full Text] [Related]
19. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
[TBL] [Abstract][Full Text] [Related]
20. Glomerular nodular lesions in non-amyloid immunoglobulin deposition disease: their pathogenetic relationship to mesangiolysis.
Ogihara T; Morita T; Miyazaki S; Hirasawa Y
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):396-402. PubMed ID: 8022113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
